Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver
- PMID: 19591196
- DOI: 10.1002/hep.23103
Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver
Abstract
An important function of hepatocytes is the biotransformation and elimination of various drugs, many of which are organic cations and are taken up by organic cation transporters (OCTs) of the solute carrier family 22 (SLC22). Because interindividual variability of OCT expression may affect response to cationic drugs such as metformin, we systematically investigated genetic and nongenetic factors of OCT1/SLC22A1 and OCT3/SLC22A3 expression in human liver. OCT1 and OCT3 expression (messenger RNA [mRNA], protein) was analyzed in liver tissue samples from 150 Caucasian subjects. Hepatic OCTs were localized by way of immunofluorescence microscopy. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and genome-wide single-nucleotide polymorphism microarray technology served to genotype 92 variants in the SLC22A1-A3/OCT1-3 gene cluster. Transport of metformin by recombinant human OCT1 and OCT3 was compared using transfected cells. OCT1 mRNA and protein expression varied 113- and 83-fold, respectively; OCT3 mRNA expression varied 27-fold. OCT1 transcript levels were on average 15-fold higher compared with OCT3. We localized the OCT3 protein to the basolateral hepatocyte membrane and identified metformin as an OCT3 substrate. OCT1 and OCT3 expression are independent of age and sex but were significantly reduced in liver donors diagnosed as cholestatic (P < or = 0.01). Several haplotypes for OCT1 and OCT3 were identified. Multivariate analysis adjusted for multiple testing showed that only the OCT1-Arg61Cys variant (rs12208357) strongly correlated with decreased OCT1 protein expression (P < 0.0001), and four variants in OCT3 (rs2292334, rs2048327, rs1810126, rs3088442) were associated with reduced OCT3 mRNA levels (P = 0.03).
Conclusion: We identified cholestasis and genetic variants as critical determinants for considerable interindividual variability of hepatic OCT1 and OCT3 expression. This indicates consequences for hepatic elimination of and response to OCT substrates such as metformin.
Comment in
-
Hepatic drug transporters, old and new: pharmacogenomics, drug response, and clinical relevance.Hepatology. 2009 Oct;50(4):1014-6. doi: 10.1002/hep.23233. Hepatology. 2009. PMID: 19787812 No abstract available.
Similar articles
-
Genetic and Epigenetic Regulation of Organic Cation Transporters.Handb Exp Pharmacol. 2021;266:81-100. doi: 10.1007/164_2021_450. Handb Exp Pharmacol. 2021. PMID: 33674913 Review.
-
Role of organic cation transporters in drug-drug interaction.Expert Opin Drug Metab Toxicol. 2015;11(10):1619-33. doi: 10.1517/17425255.2015.1069274. Epub 2015 Jul 24. Expert Opin Drug Metab Toxicol. 2015. PMID: 26206523 Review.
-
Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance.BMC Cancer. 2012 Mar 22;12:109. doi: 10.1186/1471-2407-12-109. BMC Cancer. 2012. PMID: 22439694 Free PMC article.
-
Hepatic drug transporters, old and new: pharmacogenomics, drug response, and clinical relevance.Hepatology. 2009 Oct;50(4):1014-6. doi: 10.1002/hep.23233. Hepatology. 2009. PMID: 19787812 No abstract available.
-
The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin.Clin Pharmacol Ther. 2009 Sep;86(3):299-306. doi: 10.1038/clpt.2009.92. Epub 2009 Jun 17. Clin Pharmacol Ther. 2009. PMID: 19536068
Cited by
-
The effect of genetic variants in the transcription factor TSPYL family on the CYP3A4 mediated cyclosporine metabolism in kidney transplant patients.Clin Transl Sci. 2024 Feb;17(2):e13729. doi: 10.1111/cts.13729. Clin Transl Sci. 2024. PMID: 38380703 Free PMC article.
-
Stereoselectivity in Cell Uptake by SLC22 Organic Cation Transporters 1, 2, and 3.J Med Chem. 2023 Dec 14;66(23):15990-16001. doi: 10.1021/acs.jmedchem.3c01436. Epub 2023 Dec 5. J Med Chem. 2023. PMID: 38052451 Free PMC article.
-
Genetic preservation of SLC22A3 in the Admixed and Xhosa populations living in the Western Cape.Mol Biol Rep. 2023 Dec;50(12):10199-10206. doi: 10.1007/s11033-023-08884-6. Epub 2023 Nov 4. Mol Biol Rep. 2023. PMID: 37924453 Free PMC article.
-
Structural basis of promiscuous substrate transport by Organic Cation Transporter 1.Nat Commun. 2023 Oct 11;14(1):6374. doi: 10.1038/s41467-023-42086-9. Nat Commun. 2023. PMID: 37821493 Free PMC article.
-
SLC22A3 rs2048327 Polymorphism Is Associated with Diabetic Retinopathy in Caucasians with Type 2 Diabetes Mellitus.Biomedicines. 2023 Aug 18;11(8):2303. doi: 10.3390/biomedicines11082303. Biomedicines. 2023. PMID: 37626799 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical